Study results could pave the way for potential new therapeutic option in breast cancer

被引：0
作者：
Gunawardana, Roshaine
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2012年 / 12卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：426 / 426
页数：1
相关论文
共 50 条
[41]   Chronic inflammatory bowel diseases Phase III study results with Guselkumab pave the way for approval [J].
Engels, Elke .
VISCERAL MEDICINE, 2024, 40 (04)
[42]   COMBINED IGF1R AND FAK INHIBITION AS A POTENTIAL THERAPEUTIC OPTION IN TRIPLE NEGATIVE BREAST CANCER [J].
MacMahon, D. ;
Zhou, Z. ;
Alcaide, T. ;
Liu, T. ;
McGlothen ;
Taliaferro-Smith, L. ;
O'Regan, R. .
IRISH JOURNAL OF MEDICAL SCIENCE, 2014, 183 :S545-+
[43]   Could maintenance topical tacrolimus treatment be regarded as a new therapeutic option in atopic dermatitis? [J].
Narbutt, Joanna ;
Zakrzewski, Marcin ;
Lesiak, Aleksandra .
PRZEGLAD DERMATOLOGICZNY, 2009, 96 (03) :235-239
[44]   Karanahan: A Potential New Treatment Option for Human Breast Cancer and Its Validation in a Clinical Setting [J].
Proskurina, Anastasia S. ;
Kupina, Victoria V. ;
Efremov, Yaroslav R. ;
Dolgova, Evgenia, V ;
Ruzanova, Vera S. ;
Ritter, Genrikh S. ;
Potter, Ekaterina A. ;
Kirikovich, Svetlana S. ;
Levites, Evgeniy, V ;
Ostanin, Alexandr A. ;
Chernykh, Elena R. ;
Babaeva, Oksana G. ;
Sidorov, Sergey, V ;
Bogachev, Sergey S. .
BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2022, 16
[45]   New Insights into Anticarcinogenic Properties of Adiponectin: A Potential Therapeutic Approach in Breast Cancer? [J].
Delort, Laetitia ;
Jarde, Thierry ;
Dubois, Virginie ;
Vasson, Marie-Paule ;
Caldefie-Chezet, Florence .
ADIPONECTIN, 2012, 90 :397-417
[46]   Primary chemotherapy: A better overall therapeutic option for patients with breast cancer [J].
Valero, V ;
Hortobagyi, GN .
ANNALS OF ONCOLOGY, 1998, 9 (11) :1151-1154
[47]   Glutaminase inhibition as a therapeutic option for tamoxifen-resistant breast cancer [J].
Bauerschmitz, Gerd ;
Steifensand, Friederike ;
Gallwas, Julia ;
Gruendker, Carsten .
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) :27-27
[48]   Use of monoclonal antibodies as a therapeutic option for breast cancer treatment: A review [J].
Alvarado-Arce, Aldeir ;
Rueda-Carrillo, Nazareth ;
Ramirez-Chaves, Sebastian ;
Vargas-Salas, Monica ;
Vargas-Cascante, Steven .
TECNOLOGIA EN MARCHA, 2025, 38 (03) :88-96
[49]   Non-surgical ablation for breast cancer: an emerging therapeutic option [J].
Toi, Masakazu ;
Kinoshita, Takayuki ;
Benson, John R. ;
Jatoi, Ismail ;
Kataoka, Masako ;
Han, Wonshik ;
Yamauchi, Chikako ;
Inamoto, Takashi ;
Takada, Masahiro .
LANCET ONCOLOGY, 2024, 25 (03) :e114-e125
[50]   Sulphamate Derivatives of Maslinic Acid as a Therapeutic Option for human Breast Cancer [J].
Petrenko, M. ;
Guettler, A. ;
Pflueger, E. ;
Kreuzer, M. ;
Michl, J. ;
Hulikova, A. ;
Swietach, P. ;
Harris, A. ;
Serbian, I. ;
Kahnt, M. ;
Eiselt, Y. ;
Kessler, J. ;
Csuk, R. ;
Vordermark, D. ;
Bache, M. .
STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) :S131-S132
12345